K894359Substantially Equivalent
Clotrac Citrated Whole Blood Coagulation Controls
Hemotec, Inc., Englewood CO / Traditional, Substantially Equivalent
K894359 is the FDA 510(k) clearance record for CLOTRAC CITRATED WHOLE BLOOD COAGULATION CONTROLS, a class II device, cleared for Hemotec, Inc. on under FDA product code JPA (System, Multipurpose For In Vitro Coagulation Studies). FDA records list 15 510(k) clearances for Hemotec, Inc., from to . As of , FDA records show no recalls naming K894359.
Clearance record
- Decision date
- Received
- (53 days to decision)
- Product code
- JPA System, Multipurpose For In Vitro Coagulation Studies
- Regulation
- 21 CFR 864.5425
- Device class
- Class II
- Review panel
- Hematology
- Applicant
- Hemotec, Inc. 7103 S. Revere Pkwy., Englewood CO
- Third party review
- No
Clearances, product code JPA
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 1 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
